- Metacarpal joint implants, used in the surgical treatment of degenerative joint diseases, trauma, and deformities affecting the metacarpophalangeal joints, are increasingly essential in orthopedic and hand reconstructive surgeries due to their ability to restore function, reduce pain, and improve mobility in affected fingers
- The rising prevalence of osteoarthritis and rheumatoid arthritis, especially among the elderly population, along with growing awareness of hand function restoration, is a primary driver of demand for metacarpal joint implants
- North America dominated the metacarpal joint implants market with the largest revenue share of 39.1% in 2024, characterized by advanced healthcare infrastructure, a high incidence of hand-related conditions, and the presence of major orthopedic device manufacturers, with the U.S. leading due to early adoption of innovative implant technologies
- Asia-Pacific is expected to be the fastest growing region in the metacarpal joint implants market during the forecast period due to expanding geriatric population, increasing access to orthopedic care, and rising healthcare expenditure
- Palmer Ligament segment dominated the metacarpal joint implants market with a market share of 55.2% in 2024, driven by its stabilizing the metacarpophalangeal joint and its frequent involvement in reconstructive procedures following trauma or degeneration
